Preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer is a feasible treatment strategy in the elderly

被引：1
|
作者：
Dolinsky, C. M. [1 ]
Mahmoud, N. N. [1 ]
Mick, R. [1 ]
Sun, W. [1 ]
Whittington, R. [1 ]
Solin, L. J. [1 ]
Haller, D. G. [1 ]
O'Dwyer, P. [1 ]
Fry, R. D. [1 ]
Metz, J. M. [1 ]
机构：
[1] Hosp Univ Penn, Philadelphia, PA 19104 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 66卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2006.07.583
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2178
引用
收藏
页码：S308 / S308
页数：1
相关论文
共 50 条
  • [1] Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer
    Dolinsky, CM
    Mahmoud, NN
    Mick, R
    Sun, W
    Whittington, RW
    Solin, LJ
    Haller, DG
    Fry, RD
    Metz, JM
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S277 - S277
  • [2] Improved rate of sphincter sparing surgery following preoperative chemoradiotherapy for rectal cancer with 5-FU/oxaliplatin (SFU/OX) compared to 5-fluorouracil (5-FU) alone
    Dolinsky, C. M.
    Mahmoud, N. N.
    Mick, R.
    Sun, W.
    Whittington, R. W.
    Soling, L. J.
    Haller, D. G.
    O'Dwyer, P. J.
    Fry, R. D.
    Metz, J. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S281 - S281
  • [3] Evidence for improved pathologic complete response (PCR) rate after preoperative chemoradiotherapy with 5-FU/oxaliplatin (5FU/OX) for rectal cancer.
    Dolinsky, C. M.
    Mahmoud, N. N.
    Mick, R.
    Sun, W.
    Whittington, R. W.
    Solin, L. J.
    Haller, D. G.
    Giantonio, B. J.
    O'Dwyer, P. J.
    Fry, R. D.
    Metz, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 162S - 162S
  • [4] 5-FLUOROURACIL (5-FU) IN THE TREATMENT OF PROSTATIC HYPERPLASIA
    WEI, XY
    ZHOU, XM
    [J]. UROLOGICAL RESEARCH, 1987, 15 (01): : 35 - 37
  • [5] COMPARISON OF TREATMENT OF METASTATIC GASTROINTESTINAL CANCER WITH 5-FLUOROURACIL (5-FU) TO A COMBINATION OF 5-FU WITH CYTOSINE-ARABINOSIDE
    GAILANI, S
    HOLLAND, JF
    BURNINGHAM, R
    LEONE, L
    LARSEN, V
    FALKSON, G
    [J]. CANCER, 1972, 29 (05) : 1308 - +
  • [6] Successful Treatment of Keloids with 5-Fluorouracil (5-FU)
    Weberschock, T.
    Podda, M.
    Rapprich, S.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 143 - 144
  • [7] 5-FLUOROURACIL (5-FU) PRESENTING AS A STEMI
    Okor, Ivana
    Ghosh, Priyanka
    Bhattarai, Shraddha
    Sattur, Sudhakar
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3439 - 3439
  • [8] Photosensitivity due to 5-fluorouracil (5-FU)
    von Moos, R
    Sauter, C
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 129 (1-2) : 52 - 52
  • [9] Selective delivery of 5-fluorouracil (5-FU) to ip tissues using 5-FU microspheres in rats
    Hagiwara, A
    Sakakura, C
    Tsujimoto, H
    Imanishi, T
    Ohgaki, M
    Yamasaki, J
    Sawai, K
    Takahashi, T
    Fujita, T
    Yamamoto, A
    Muranishi, S
    Ikada, Y
    [J]. ANTI-CANCER DRUGS, 1997, 8 (02) : 182 - 188
  • [10] Methotrexate (MTX) and 5-fluorouracil (5-FU) in advanced colorectal cancer patients previously treated with adjuvant 5-FU
    Pronzato, P
    Vaira, F
    Viganni, A
    Losardo, P
    Bertelli, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 760 - 760
12345